1st years you three have following homeworks and present to me! - [ ] Sleep elaboration points - [ ] Appetite elaboration points - [ ] List common prescribed drug induced depression Anxiety Psychotic features - [ ] List common prescribed physical illness drugs interacting with psychotropics - [ ] What does family dynamics mean? - [ ] Whats the significance of knowing pathways of care ?
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
I now have enough from the textbooks to compile a thorough answer across all 6 homework topics. Here is the full presentation:
🎓 First Years' Homework Presentation
1. Sleep - Elaboration Points
(Kaplan & Sadock's Comprehensive Textbook of Psychiatry)
Sleep disturbances are among the most common manifestations of psychiatric illness. The alterations may involve timing, amount, quality, and the occurrence of abnormal events during sleep. They may arise from:
- The primary psychiatric disorder itself
- Medications used in psychiatric treatment
- Other prescribed agents or substance use
Insomnia
Defined subjectively as the sensation of not sleeping well or enough. It is a common, often chronic sign of:
- Depression (classically terminal insomnia - early morning awakening, especially melancholic depression)
- Generalised anxiety disorder and panic disorder
- Mania/hypomania (diminished need for sleep - patient often does not complain about this)
- Acute schizophrenia
- Substance use disorders
- Alcohol or stimulant ingestion, or sedative-hypnotic discontinuation
Clinically, while much attention is paid to distinguishing patterns (initial vs. middle vs. terminal insomnia), the clinical usefulness of these distinctions is sometimes unclear.
Hypersomnia
Excessive nighttime sleep or excessive daytime sleepiness. Less common than insomnia but seen in:
- Depression with bipolar features (atypical depression)
- Stimulant withdrawal
- Excessive use of sedatives or tranquilisers
- Narcolepsy - sudden irresistible attacks of sleep, often with cataplexy, sleep paralysis, and hypnagogic hallucinations; attacks precipitated by intense emotion (e.g. laughter, orgasm)
- Sleep apnea - intermittent airway obstruction from soft palate abnormality; snoring, breath pauses, gasping; associated daytime fatigue
- Kleine-Levin syndrome - periodic hypersomnia in young men; alternates with confusional states, ravenous hunger, hypersexuality
Parasomnias
- Somnambulism (sleepwalking) - aimless wandering with incomplete arousal; can be precipitated by psychotropic medications (e.g. sedative-hypnotics, z-drugs)
- Sleep terror disorder - acute anxiety and physiologic arousal without awakening
- Nightmares - common in PTSD, anxiety and mood disorders; can also be a medication side effect
- Vivid/intense dreams - may occur with SSRIs (as seen in clinical practice; a patient on SSRI for depression can develop shorter, fragmented but unusually vivid dreams)
Sensory/Motor Sleep Symptoms
- Restless legs syndrome - peculiar sensations in legs causing irresistible need to move; worsens at rest/at night
- Nocturnal myoclonus - repetitive myoclonic jerking of legs during sleep, disturbs both patient and partner
2. Appetite - Elaboration Points
(Kaplan & Sadock's Comprehensive Textbook of Psychiatry)
A significant change in appetite and weight can be seen in both medical and psychiatric illness.
Decreased Appetite (Anorexia)
- Common in depression, grief, and some anxiety disorders
- Occurs in the latter stages of chronic medical illness
- May be secondary to alterations in taste sensation (from psychiatric disturbance or medication side effects)
- In anorexia nervosa: patient actively resists hunger to restrict intake and achieve a physiologically unrealistic low weight
Increased Appetite (Hyperphagia)
- Occurs in some depressed patients, especially those with a history of mania or hypomania (atypical depression)
- Binge eating (up to several thousand calories per episode) occurs as an attempt to self-soothe during emotional tension - key feature of bulimia nervosa and binge-eating disorder
- Increased appetite as a medication side effect: many psychotropics, especially atypical antipsychotics (e.g. olanzapine, clozapine, quetiapine) can cause significant weight gain through appetite stimulation
- Rare organic causes: hypothalamic disorders, Klüver-Bucy syndrome (bilateral temporal lobe dysfunction) - associated with emotional placidity, hypersexuality, hyperorality, and hyperphagia
Clinical Pearl
The feedback loop is important: e.g. weight loss in anorexia nervosa causes starvation effects including preoccupation with food, which exacerbates the disorder itself. Similarly, the insomnia of mania worsens the mania if untreated.
3. Common Prescribed Drug-Induced Psychiatric Symptoms
(Maudsley Prescribing Guidelines + Kaplan & Sadock + Clinical Pharmacology)
A. Drug-Induced Depression
| Drug Class | Examples |
|---|---|
| Antihypertensives | Beta-blockers (propranolol, atenolol), methyldopa, clonidine, reserpine |
| Corticosteroids | Prednisolone, dexamethasone (also euphoria - biphasic) |
| Hormonal agents | Oral contraceptives, progestins, finasteride |
| Cardiovascular | Digoxin, statins (controversial), amiodarone |
| Neurological | Levodopa, barbiturates, benzodiazepines (long-term) |
| Gastrointestinal | Metoclopramide, ranitidine (older H2 blockers) |
| Antivirals/Antibiotics | Interferon-alpha, efavirenz (ARV), fluoroquinolones |
| Cancer drugs | Tamoxifen, vincristine, procarbazine |
B. Drug-Induced Anxiety
| Drug Class | Examples |
|---|---|
| Stimulants | Salbutamol/albuterol (beta-2 agonists), theophylline, caffeine-containing drugs |
| Thyroid | Levothyroxine (excess dose) |
| Sympathomimetics | Pseudoephedrine, decongestants |
| Corticosteroids | Prednisolone, dexamethasone |
| Antidepressants (early use) | SSRIs/SNRIs can cause initial activation/jitteriness |
| Withdrawal states | Benzodiazepines, alcohol, opioids |
| Antihistamines (paradoxical) | Especially in elderly |
| Dopaminergic agents | Levodopa, dopamine agonists |
C. Drug-Induced Psychotic Features
| Drug Class | Examples |
|---|---|
| Corticosteroids | High-dose prednisolone, ACTH ("steroid psychosis") |
| Dopaminergic | Levodopa, bromocriptine, amantadine |
| Stimulants | Amphetamines, methylphenidate (at high doses) |
| Antimalarials | Mefloquine, chloroquine |
| Antiviral/antiretroviral | Efavirenz, acyclovir (high dose) |
| Antibiotics | Fluoroquinolones (ciprofloxacin), isoniazid |
| Anticholinergics | Atropine, benztropine, oxybutynin (especially in elderly) |
| Analgesics | Tramadol, ketamine, pentazocine |
| Cardiovascular | Digoxin toxicity |
4. Common Prescribed Physical Illness Drugs Interacting with Psychotropics
(Maudsley Prescribing Guidelines + Clinical Pharmacology)
| Physical Illness Drug | Psychotropic | Interaction / Risk |
|---|---|---|
| Beta-blockers (propranolol) | Antipsychotics (chlorpromazine, thioridazine) | Additive hypotension; propranolol raises antipsychotic plasma levels |
| Digoxin | Carbamazepine, phenytoin | Enzyme inducers reduce digoxin levels; risk of cardiac arrhythmia |
| Warfarin | SSRIs, carbamazepine, valproate | SSRIs inhibit platelet aggregation → increased bleeding; carbamazepine induces CYP2C9 → reduces warfarin effect; valproate displaces warfarin from protein binding |
| ACE inhibitors / ARBs | Lithium | Reduced renal clearance of lithium → lithium toxicity |
| NSAIDs (ibuprofen, diclofenac) | Lithium, SSRIs | NSAIDs reduce lithium excretion → toxicity; combined with SSRIs → increased GI bleeding risk |
| Theophylline | Lithium, fluvoxamine | Theophylline increases lithium excretion → subtherapeutic levels; fluvoxamine inhibits CYP1A2 → theophylline toxicity |
| Rifampicin (anti-TB) | Benzodiazepines, antipsychotics, antidepressants | Potent CYP3A4 inducer → dramatically reduces plasma levels of many psychotropics |
| Antifungals (fluconazole, ketoconazole) | Quetiapine, midazolam, TCAs | CYP3A4 inhibition → increased psychotropic levels → toxicity/QTc prolongation |
| Macrolide antibiotics (erythromycin, clarithromycin) | Quetiapine, clozapine, TCAs | CYP3A4 inhibition → raised levels + QTc prolongation |
| Fluoroquinolones (ciprofloxacin) | Clozapine | CYP1A2 inhibition → raised clozapine levels → seizure risk |
| Carbamazepine (as a physical illness drug, e.g. trigeminal neuralgia) | Antipsychotics, antidepressants, OCP | Enzyme induction → reduced efficacy of co-prescribed psychotropics and hormonal contraceptives |
| Cimetidine (H2 blocker) | Benzodiazepines, TCAs | CYP inhibition → increased levels |
| Calcium channel blockers (verapamil, diltiazem) | Carbamazepine, lithium | Verapamil/diltiazem inhibit CYP3A4 → raised carbamazepine levels; both can worsen neurotoxicity with lithium |
| Thiazide diuretics | Lithium | Reduce renal sodium → compensatory lithium reabsorption → lithium toxicity |
5. What Does Family Dynamics Mean?
Family dynamics refers to the patterns of interaction, relationships, roles, communication styles, power structures, and emotional processes that operate within a family unit and shape how family members relate to one another and to the outside world.
In a psychiatric context, family dynamics are assessed because they:
-
Influence the onset and course of psychiatric illness - A family environment characterised by high expressed emotion (criticism, hostility, over-involvement) is a well-established risk factor for relapse in schizophrenia and mood disorders.
-
Provide information about the patient's developmental history - The quality of early attachment, parenting style, and family cohesion shapes personality development and vulnerability to mental illness.
-
Reveal current stressors and supports - Who the patient lives with, how conflicts are handled, whether there is a supportive or chaotic home environment all have direct bearing on prognosis and treatment planning.
-
Identify enmeshment, triangulation, or scapegoating - Dysfunctional patterns such as a child being drawn into parental conflict (triangulation) or one family member being identified as "the problem" while family-level dysfunction goes unaddressed (scapegoating).
-
Guide treatment - Family therapy, psychoeducation for relatives, and discharge planning all depend on understanding family dynamics.
Key domains assessed:
- Marital/couple relationship quality
- Parent-child relationships and attachment
- Sibling relationships and bullying
- Communication patterns (open vs. secretive, aggressive vs. assertive)
- Roles (rigid vs. flexible)
- Boundaries (enmeshed vs. disengaged)
- Cultural and generational influences
(Kaplan and Sadock's Synopsis of Psychiatry; Kaplan & Sadock's Comprehensive Textbook of Psychiatry)
6. Significance of Knowing Pathways of Care
Pathways of care (also called care pathways or clinical pathways) describe the sequence of steps, services, and providers a patient moves through from initial presentation to ongoing management or recovery within the health system.
Why This Matters in Psychiatry:
1. Reducing delays in treatment
Many patients with mental illness go years without appropriate care due to unclear or poorly communicated care pathways. Understanding these pathways helps clinicians and commissioners identify and close gaps.
2. Standardising assessment and intervention
Clinical pathways standardise the steps from triage through assessment, diagnosis, intervention, and disposition - particularly important in acute settings (e.g. psychiatric emergency departments) where variability can harm patients.
3. Matching patient need to the right level of care
Care pathways define when a patient needs primary care vs. community mental health teams vs. inpatient admission vs. specialist services (e.g. forensic, CAMHS, liaison psychiatry). Getting this wrong causes either under-treatment (patient in primary care when they need inpatient) or over-treatment (blocking an inpatient bed when community care would suffice).
4. Facilitating communication between services
Knowing the pathway means knowing who to refer to, how, and when - improving continuity of care and reducing patients "falling through the cracks" between services.
5. Informing service planning and resource allocation
Commissioners and policy makers use knowledge of pathways to identify bottlenecks, plan capacity, and allocate resources where they are most needed.
6. Empowering patients and carers
When patients and families understand the pathway, they can navigate the system more effectively, know what to expect at each stage, and advocate for themselves if care is not being delivered appropriately.
7. Research and quality improvement
Pathways provide the framework for auditing outcomes at each step, identifying where patients disengage or deteriorate, and designing targeted improvements.
(Kaplan & Sadock's Comprehensive Textbook of Psychiatry - Models of Care and Innovations)
Sources: Kaplan & Sadock's Comprehensive Textbook of Psychiatry; Kaplan and Sadock's Synopsis of Psychiatry; The Maudsley Prescribing Guidelines in Psychiatry (15th ed); Goodman & Gilman's Pharmacological Basis of Therapeutics
This is a shared conversation. Sign in to Orris to start your own chat.